case_images: PMC7661127_01
case_images: Cutis marmorata, a rash typically associated with severe decompression sickness, was present on arrival to the hyperbaric chamber.
case_images: CRICC2020-8855060.001.jpg
case_images: PMC7661127_01_CRICC2020-8855060.001.jpg
case_images: fig1
case_images: He developed cutis marmorata (Figure 1), a rash typically associated with severe DCS.
case_images: Time course of crystalloid administered upon arrival at the medical center with hyperbaric capabilities. Solid bars show timing of hyperbaric oxygen treatment (HBO) and norepinephrine (Norepi), vasopressin (Vaso), and epinephrine (Epi) infusions. The darkest color intensity indicates maximum vasopressor dose (Norepi, 30 mcg/min; Vaso, 0.04 units/min; Epi, 10 mcg/min), faded intensity indicates taper of dose, and absence of bar indicates discontinuation of vasopressor. Mean arterial pressure (not shown) was 55-65 mm Hg throughout this period.
case_images: CRICC2020-8855060.002.jpg
case_images: PMC7661127_01_CRICC2020-8855060.002.jpg
case_images: fig2
case_images: During the initial 37 hours of hospitalization, 22 liters of crystalloid and multiple albumin boluses were administered for refractory hypotension at which time blood pressure normalized and all vasopressors had been discontinued (Figure 2).